The pathogenetic features of cerebral cavernous malformations: a comprehensive review with therapeutic implications.
暂无分享,去创建一个
[1] R. Shenkar,et al. Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity , 2010, The Journal of experimental medicine.
[2] E. Tournier-Lasserve,et al. Recent insights into cerebral cavernous malformations: the molecular genetics of CCM , 2010, The FEBS journal.
[3] C. Albigès-Rizo,et al. Recent insights into cerebral cavernous malformations: a complex jigsaw puzzle under construction , 2010, The FEBS journal.
[4] Dean Y. Li,et al. Recent insights into cerebral cavernous malformations: animal models of CCM and the human phenotype , 2010, The FEBS journal.
[5] N. Sciaky,et al. Rho Kinase Inhibition Rescues the Endothelial Cell Cerebral Cavernous Malformation Phenotype* , 2010, The Journal of Biological Chemistry.
[6] E. Golanov,et al. Biology of Vascular Malformations of the Brain , 2009, Stroke.
[7] Christopher A. Jones,et al. Corrigendum: The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases , 2009, Nature Network Boston.
[8] Christopher A. Jones,et al. The Cerebral Cavernous Malformation signaling pathway promotes vascular integrity via Rho GTPases , 2009, Nature Medicine.
[9] N. Petit,et al. Patterns of expression of the three cerebral cavernous malformation (CCM) genes during embryonic and postnatal brain development. , 2006, Gene expression patterns : GEP.
[10] M. Vikkula,et al. Cerebral cavernous malformation: new molecular and clinical insights , 2006, Journal of Medical Genetics.
[11] A. Louvi,et al. CCM2 expression parallels that of CCM1. , 2006, Stroke.
[12] H. Matsunami,et al. Neuronal expression of the Ccm2 gene in a new mouse model of cerebral cavernous malformations , 2006, Mammalian Genome.
[13] D. Marchuk,et al. CCM1 and CCM2 protein interactions in cell signaling: implications for cerebral cavernous malformations pathogenesis. , 2005, Human molecular genetics.
[14] M. Clanet,et al. Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations. , 2005, American journal of human genetics.
[15] G. Davis,et al. Microtubule Depolymerization Rapidly Collapses Capillary Tube Networks in Vitro and Angiogenic Vessels in Vivo through the Small GTPase Rho* , 2004, Journal of Biological Chemistry.
[16] C. Liquori,et al. Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations. , 2003, American journal of human genetics.
[17] A. Straube,et al. Molecular genetic investigations in the CCM1 gene in sporadic cerebral cavernomas , 2003, Neurology.
[18] Crone,et al. The natural history of cavernous malformations: a prospective study of 68 patients , 1999, Neurosurgery.
[19] John R. Robinson,et al. Natural history of the cavernous angioma. , 1991, Journal of neurosurgery.
[20] B. Rilliet,et al. [131 cases of cavernous angioma (cavernomas) of the CNS, discovered by retrospective analysis of 24,535 autopsies]. , 1989, Neuro-Chirurgie.